Ifosfamide-induced encephalopathy due to a novel formulation of ifosfamide
Author:
Affiliation:
1. Department of Pediatric Hematology and Oncology; Rouen University Hospital; Rouen France
2. Department of Pharmacy; Rouen University Hospital; Rouen France
3. Laboratory MERCI EA 3829; University of Rouen; France
Publisher
Wiley
Subject
Oncology,Hematology,Pediatrics, Perinatology, and Child Health
Reference8 articles.
1. Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites;Kerbusch;Clin Pharmacokinet,2001
2. Prediction of ifosphamide/mesna associated encephalopathy;Meanwell;Eur J Cancer Clin Oncol,1986
3. Central nervous system effect following ifosfamide monotherapy of advanced renal carcinoma;Heim;J Cancer Res Clin Oncol,1981
4. Evaluating risk factors for the development of ifosfamide encephalopathy;David;Am J Clin Oncol,2005
5. Ifosfamide neurotoxicity is related to previous cisplatin treatment for pediatric solid tumors;Pratt;J Clin Oncol,1990
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A novel case of prolonged Ifosfamide encephalopathy and long-term treatment with methylene blue: a case report and review of literature;BMC Pediatrics;2022-02-02
2. Reversible Encepahlopathy Induced by Ifosfamide with Brain Imaging;Global Pediatric Health;2021-01
3. Ifosfamide‐induced encephalopathy: Brand‐name (HOLOXAN®) vs generic formulation (IFOSFAMIDE EG®);Journal of Clinical Pharmacy and Therapeutics;2019-03-04
4. Neurological Complications of the Treatment of Pediatric Neoplastic Disorders;Pediatric Neurology;2018-08
5. Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell Transplantation;Frontiers in Pediatrics;2017-05-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3